DAMAC Invites the World to Apply for “The Ultimate DAMAC Islander”
Notified -
Globe Newswire24-10-2025, 23:02
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade 9-10-2025, 17:05